Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Conditions:   Recurrent Solid Tumor;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Malignant Germ Cell Tumor;   Recurrent Malignant Solid Neoplasm;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Peripheral Primitive Neuroectodermal Tumor;   Recurren t Rhabdoid Tumor;   Recurrent Rhabdomyosarcoma;   Recurrent Soft Tissue Sarcoma;   Recurrent Wilms Tumor;   Refractory Ewing Sarcoma;   Refractory Hepatoblastoma;   Refractory Malignant Germ Cell Tumor;   Refractory Malignant Solid Neoplasm;   Refractory Neuroblastoma;   Refractory Osteosarcoma;   Refractory Peripheral Primitive Neuroectodermal Tumor;   Refractory Rhabdoid Tumor;   Refractory Rhabdomyosarcoma;   Refractory Soft Tissue Sarcoma Interventions:   Drug: Onivyde;   Drug: Talazoparib;   Drug: Temozolomide Sponsors:   St. Jude Children's Research Hospital;   Pfizer;   Ipsen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials